Impact of COVID-19 on the development of major mental disorders in patients visiting a university hospital: a retrospective observational study
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: This study aimed to investigate the impact of coronavirus disease 2019 (COVID-19) on the development of major mental disorders in patients visiting a university hospital. Methods: The study participants were patients with COVID-19 (n=5,006) and those without COVID-19 (n=367,162) registered in the database of Keimyung University Dongsan Hospital and standardized with the Observational Medical Outcomes Partnership Common Data Model. Data on major mental disorders that developed in both groups over the 5-year follow-up period were extracted using the FeederNet computer program. A multivariate Cox proportional hazards model was used to estimate the hazard ratio (HR) and 95% confidence interval (CI) for the incidence of major mental disorders. Results: The incidences of dementia and sleep, anxiety, and depressive disorders were significantly higher in the COVID-19 group than in the control group. The incidence rates per 1,000 patient-years in the COVID-19 group vs. the control group were 12.71 vs. 3.76 for dementia, 17.42 vs. 7.91 for sleep disorders, 6.15 vs. 3.41 for anxiety disorders, and 8.30 vs. 5.78 for depressive disorders. There was no significant difference in the incidence of schizophrenia or bipolar disorder between the two groups. COVID-19 infection increased the risk of mental disorders in the following order: dementia (HR, 3.49; 95% CI, 2.45–4.98), sleep disorders (HR, 2.27; 95% CI, 1.76–2.91), anxiety disorders (HR, 1.90; 95% CI, 1.25–2.84), and depressive disorders (HR, 1.54; 95% CI, 1.09–2.15). Conclusion: This study showed that the major mental disorders associated with COVID-19 were dementia and sleep, anxiety, and depressive disorders.
Abstract
Background: This study aimed to investigate the impact of coronavirus disease 2019 (COVID-19) on the development of major mental disorders in patients visiting a university hospital. Methods: The study participants were patients with COVID-19 (n=5,006) and those without COVID-19 (n=367,162) registered in the database of Keimyung University Dongsan Hospital and standardized with the Observational Medical Outcomes Partnership Common Data Model. Data on major mental disorders that developed in both groups over the 5-year follow-up period were extracted using the FeederNet computer program. A multivariate Cox proportional hazards model was used to estimate the hazard ratio (HR) and 95% confidence interval (CI) for the incidence of major mental disorders. Results: The incidences of dementia and sleep, anxiety, and depressive disorders were significantly higher in the COVID-19 group than in the control group. The incidence rates per 1,000 patient-years in the COVID-19 group vs. the control group were 12.71 vs. 3.76 for dementia, 17.42 vs. 7.91 for sleep disorders, 6.15 vs. 3.41 for anxiety disorders, and 8.30 vs. 5.78 for depressive disorders. There was no significant difference in the incidence of schizophrenia or bipolar disorder between the two groups. COVID-19 infection increased the risk of mental disorders in the following order: dementia (HR, 3.49; 95% CI, 2.45–4.98), sleep disorders (HR, 2.27; 95% CI, 1.76–2.91), anxiety disorders (HR, 1.90; 95% CI, 1.25–2.84), and depressive disorders (HR, 1.54; 95% CI, 1.09–2.15). Conclusion: This study showed that the major mental disorders associated with COVID-19 were dementia and sleep, anxiety, and depressive disorders.
참고문헌 (34)
- Moeti M, "Global pandemic perspectives : public health, mental health, and lessons for the future", Lancet, 400, pp.e3~e7 (2022)
- Torales J, "The outbreak of COVID-19 coronavirus and its impact on global mental health", Int J Soc Psychiatry, 66, pp.317~320 (2020)
- Jin Y, "Mass quarantine and mental health during COVID-19 : a meta-analysis", J Affect Disord, 295, pp.1335~1346 (2021)
- Walton M, "Mental health care for medical staff and affiliated healthcare workers during the COVID-19 pandemic", Eur Heart J Acute Cardiovasc Care, 9, pp.241~247 (2020)
- Brooks SK, "The psychological impact of quarantine and how to reduce it : rapid review of the evidence", Lancet, 395, pp.912~920 (2020)
- Dubey S, "Psychosocial impact of COVID-19", Diabetes Metab Syndr, 14, pp.779~788 (2020)
- Manchia M, "The impact of the prolonged COVID-19 pandemic on stress resilience and mental health : a critical review across waves", Eur Neuropsychopharmacol, 55, pp.22~83 (2022)
- Jeamjitvibool T, "The association between resilience and psychological distress during the COVID-19 pandemic : a systematic review and meta-analysis", Int J Environ Res Public Health, 19, pp.14854~ (2022)
- Wu Y, "Nervous system involvement after infection with COVID-19 and other coronaviruses", Brain Behav Immun, 87, pp.18~22 (2020)
- Mao L, "Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China", JAMA Neurol, 77, pp.683~690 (2020)
- Tavares-Júnior JW, "COVID-19 associated cognitive impairment : a systematic review", Cortex, 152, pp.77~97 (2022)
- Hripcsak G, "Observational Health Data Sciences and Informatics(OHDSI) : opportunities for observational researchers", Stud Health Technol Inform, 216, pp.574~578 (2015)
- "FeederNet: a distributed clinical data analysis platform in Korea" (2022)[URL]
- Tian Y, "Evaluating large-scale propensity score performance through real-world and synthetic data experiments", Int J Epidemiol, 47, pp.2005~2014 (2018)
- Romano PS, "Adapting a clinical comorbidity index for use with ICD-9-CM administrative data : differing perspectives", J Clin Epidemiol, 46, pp.1075~1079 (1993)
- Rubin DB, "Using propensity scores to help design observational studies : application to the tobacco litigation", Health Serv Outcomes Res Methodol, 2, pp.169~188 (2001)
- "SNOEMD clinical terms" (2019)[URL]
- World Health Organization(WHO), "International Statistical Classification of Diseases and Related Health Problems" (2004), WHO
- Rassen JA, "One-to-many propensity score matching in cohort studies", Pharmacoepidemiol Drug Saf, 21(Suppl 2), pp.69~80 (2012)
- Taquet M, "Bidirectional associations between COVID-19 and psychiatric disorder : retrospective cohort studies of 62 354 COVID-19 cases in the USA", Lancet Psychiatry, 8, pp.130~140 (2021)
- Gollop C, "Incidence of newly-diagnosed dementia after COVID-19 infection versus acute upper respiratory infection : a retrospective cohort study", J Alzheimers Dis, 93, pp.1033~1040 (2023)
- Freudenberg-Hua Y, "Psychotropic medication use is associated with greater 1-year incidence of dementia after COVID-19 hospitalization", Front Med(Lausanne), 9, pp.841326~ (2022)
- Taquet M, "Neurological and psychiatric risk trajectories after SARS-CoV-2 infection : an analysis of 2-year retrospective cohort studies including 1 284 437 patients", Lancet Psychiatry, 9, pp.815~827 (2022)
- Xie Y, "Risks of mental health outcomes in people with COVID-19 : cohort study", BMJ, 376, pp.e068993~ (2022)
- Hosp JA, "Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19", Brain, 144, pp.1263~1276 (2021)
- Spudich S, "Nervous system consequences of COVID-19", Science, 375, pp.267~269 (2022)
- Lyra E Silva NM, "Inflammation at the crossroads of COVID-19, cognitive deficits and depression", Neuropharmacology, 209, pp.109023~ (2022)
- Bhat S, "Sleep disorders and COVID-19", Sleep Med, 91, pp.253~261 (2022)
- Tedjasukmana R, "Sleep disturbance in post COVID-19 conditions : prevalence and quality of life", Front Neurol, 13, pp.1095606~ (2023)
- Witthauer C, "Comorbidity of infectious diseases and anxiety disorders in adults and its association with quality of life : a community study", Front Public Health, 2, pp.80~ (2014)
- Fardin MA, "COVID-19 and anxiety : a review of psychological impacts of infectious disease outbreaks", Arch Clin Infect Dis, 15(COVID-19), pp.e102779~ (2020)
- Mazza MG, "Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment", CNS Drugs, 36, pp.681~702 (2022)
- Kim D, "Post-recovery stigma in early and late COVID-19 epidemic", Keimyung Med J, 41, pp.80~83 (2022)
- Taquet M, "6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19 : a retrospective cohort study using electronic health records", Lancet Psychiatry, 8, pp.416~427 (2021)